Loading live market data…

Kymera Therapeutics, Inc.

NASDAQ:KYMR

$114.12 USD

$2.04 (1.82%)

Volume
411.01K
Average Volume
794.36K
Market Capitalization
$9.39B
P/E Ratio
-31.88
Dividend Yield
0.00%
Price Target
$129.00
Year High
$130.05
Year Low
$36.65
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$10.81

KYMR Estimated and Actual Revenue by Quarter

KYMR Estimated and Actual EPS by Quarter

KYMR Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 6 -43.91M -2.97M -12.5M -43.91M -2.97M -12.5M
2027-09-30 6 -43.91M -2.97M -12.5M -43.91M -2.97M -12.5M
2027-06-30 6 -43.91M -2.97M -12.5M -43.91M -2.97M -12.5M
2027-03-31 6 -39.52M -2.67M -11.25M -39.52M -2.67M -11.25M
2026-12-31 6 -37.73M -2.55M -10.74M -37.73M -2.55M -10.74M
2026-09-30 13 -16.42M -5.33M -8.78M -16.42M -5.33M -8.78M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 6 -438.36M -920.83K -102.74M 3.1M 45.89M 13.06M
2027-09-30 6 -422.27M -887.03K -98.97M 3.1M 45.89M 13.06M
2027-06-30 6 -432.14M -907.76K -101.28M 3.1M 45.89M 13.06M
2027-03-31 6 -422.26M -887K -98.97M 2.79M 41.3M 11.76M
2026-12-31 6 -421.99M -886.45K -98.91M 2.67M 39.43M 11.22M
2026-09-30 13 -118.6M -69.35M -99.51M 5.57M 17.16M 9.17M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 6 2.97M 43.91M 12.5M 6 -4.49441 -0.00944109 -1.0534
2027-09-30 6 2.97M 43.91M 12.5M 7 -4.32942 -0.00909451 -1.01473
2027-06-30 6 2.97M 43.91M 12.5M 6 -4.43063 -0.0093071 -1.03845
2027-03-31 6 2.67M 39.52M 11.25M 10 -4.3293 -0.00909424 -1.0147
2026-12-31 6 2.55M 37.73M 10.74M 10 -4.32661 -0.00908859 -1.01407
2026-09-30 13 5.33M 16.42M 8.78M 14 -1.21601 -0.71106 -1.02021